Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
Clinical trial NCT01440582 · COMPLETED
Trial details
- NCT number
- NCT01440582
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-18
- Primary completion
- 2019-02-28
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.